Christopher P. Lowe - 05 Oct 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role: COO & Chief Financial Officer
Signature: /s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Issuer symbol: QNCX
Transactions as of: 05 Oct 2021
Net transactions value: -$216,635
Form type: 4
Filing time: 07 Oct 2021, 18:24:12 UTC
Previous filing: 18 Aug 2021
Next filing: 16 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QNCX	Common Stock	Options Exercise	$272,221	+4,963	+8.3%	$54.85	64,963	05 Oct 2021	Direct
transaction	QNCX	Common Stock	Sale	$488,856	-4,963	-7.6%	$98.50^*	60,000	05 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QNCX	Stock Option (Right to Buy)	Options Exercise	$0	-4,963	-5%	$0.000000	95,037	05 Oct 2021	Common Stock	4,963	$54.85	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	1/48th of the shares subject to the option shall vest and become exercisable monthly over four years.